Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Apr;121(4):258-64.
doi: 10.1016/j.amjmed.2007.10.040.

Complications of viral influenza

Michael B Rothberg  1 , Sarah D Haessler, Richard B Brown
Affiliations
Review

Complications of viral influenza

Michael B Rothberg et al. Am J Med. 2008 Apr.

Abstract

Viral influenza is a seasonal infection associated with significant morbidity and mortality. In the United States more than 35,000 deaths and 200,000 hospitalizations due to influenza occur annually, and the number is increasing. Children aged less than 1 year and adults aged more than 65 years, pregnant woman, and people of any age with comorbid illnesses are at highest risk. Annual vaccination is the cornerstone of prevention, but some older patients may derive less benefit from immunization than otherwise fit individuals. If started promptly, antiviral medications may reduce complications of acute influenza, but increasing resistance to amantadine and perhaps neuraminidase inhibitors underscores the need for novel prevention and treatment strategies. Pulmonary complications of influenza are most common and include primary influenza and secondary bacterial infection. Either may cause pneumonia, and each has a unique clinical presentation and pathologic basis. Staphylococcus aureus, including methicillin-resistant strains, is an important cause of secondary bacterial pneumonia with high mortality. During influenza season, treatment of pneumonia should include empiric coverage for this pathogen. Neuromuscular and cardiac complications are unusual but may manifest in persons of any age.

PubMed Disclaimer

Figures

Figure
Figure
Annual risk of hospitalization for high-risk and non–high-risk persons.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thompson W.W., Shay D.K., Weintraub E. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–186. - PubMed
    1. Thompson W.W., Shay D.K., Weintraub E. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333–1340. - PubMed
    1. Simonsen L., Taylor R., Viboud C. US flu mortality estimates are based on solid science. BMJ. 2006;332:177–178. - PMC - PubMed
    1. Simonsen L., Reichert T.A., Viboud C. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165:265–272. - PubMed
    1. Dushoff J., Plotkin J.B., Viboud C. Mortality due to influenza in the United States—an annualized regression approach using multiple-cause mortality data. Am J Epidemiol. 2006;163:181–187. - PubMed

MeSH terms

Substances